Here's How Much You Would Have Made Owning Krystal Biotech Stock In The Last 5 Years
Domino's Pizza To $510? Here Are 10 Top Analyst Forecasts For Wednesday
How Is The Market Feeling About Krystal Biotech?
Immunovant Stock Falls 8% Amid Graves' Disease Program Update
Fulcrum Therapeutics Upgraded: BofA Debates Pivotal Study Success For Losmapimod In Rare Genetic Muscle Disease
Cantor Fitzgerald Reiterates Overweight on Immunovant
Immunovant Analyst Ratings
What's Going In With Vivek Ramaswamy-Founded Roivant Sciences Stock On Monday?
Arcellx Analyst Ratings
Top 2 Health Care Stocks That May Collapse This Quarter
Immunovant Reports Phase 2a Results for Graves' Disease Drug, FDA Clears Pivotal Trial
Amicus Started at Buy by Jefferies, Viewed as "Growth at Reasonable Price"
J&J Submits FDA Application for Myasthenia Gravis Drug Nipocalimab
Cantor Fitzgerald Reiterates Overweight on Krystal Biotech
Evercore ISI Group Maintains Outperform on Avidity Biosciences, Lowers Price Target to $53
These Are the Stocks With the Largest Changes in Short Interest in July - GS
JP Morgan Maintains Overweight on Amicus Therapeutics, Lowers Price Target to $16
Amicus Therapeutics Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Denali Therapeutics, Maintains $90 Price Target
Denali Therapeutics Analyst Ratings